Skip to main content
. Author manuscript; available in PMC: 2014 Jan 15.
Published in final edited form as: Clin Cancer Res. 2012 Dec 3;19(2):347–356. doi: 10.1158/1078-0432.CCR-12-2046

Figure 5.

Figure 5

CD74-IL-DEX extends survival of SCID mice bearing Raji xenografts. A, survival curve of SCID mice treated with various drugs. All control groups died within days 14 to 15 days postengraftment. CD74-ILs increased the mean survival by 6.35 days compared with CD74 treatment alone (P = 0.0405). CD74-IL-DEX liposome group survived an average of 13.56 days longer than CD74-ILs group (P = 0.0002) and increased mean survival by 29.4 days compared with controls (P = 0.0002). B, statistical analysis using ANOVA to compare mean days of survival among groups. A summary of statistical results is presented in Table 1. HER, Herceptin.